112289 ⎘
Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Delivery of Polynucleotides Across the Blood-Brain-Barrier Using Recombinant AAV9
#902Transposition of maize elements in vertebrates
#903REAGENTS AND METHODS FOR MODULATING CONE PHOTORECEPTOR ACTIVITY
#904Chimeric gene constructs for generation of fluorescent transgenic ornamental fish
#905Stem cell beacon
#906Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases
#907Methods for modulating embryonic stem cell differentiation
#908THERAPEUTIC REGIMEN FOR TREATING CANCER
#909Isolation and growth of stem cells from hemangiomas
#910Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
#911TRUNCATED ACTIVIN TYPE II RECEPTOR AND METHODS OF USE
#912METHODS AND COMPOSITIONS FOR THE TREATMENT OF CIRRHOSIS AND LIVER FIBROSIS
#913VECTORS FOR DELIVERY OF LIGHT SENSITIVE PROTEINS AND METHODS OF USE
#914Methods for producing microRNAs
#915Nucleic acid construct having an ovalbumin promotor
#916Materials and methods for the treatment of pathological neovascularization in the eye
#917Novel Glutamic Acid Decarboxylase (GAD) Chimera And Methods Of Use
#918MIR-21 promoter driven targeted cancer therapy
#919NON-AD5 ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
#920Gene delivery system and method of use
#921Floral Transition Genes in Maize and Uses Thereof
#922Methods for Conditional and Inducible Transgene Expression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells
#923METHODS AND COMPOSITIONS FOR INHIBITING PROPAGATION OF VIRUSES USING RECOMBINANT TETHERIN CONSTRUCTS
#924Polypeptides for Specific Targeting to Otx2 Target Cells
#925Recombinant adenovirus target-oriented co-expressing human p53 and p53aip1
#926NEUROD1 GENE EXPRESSION IN NON-ENDOCRINE PANCREATIC EPITHELIAL CELLS (NEPECs)
#927Therapeutic retroviral vectors for gene therapy
#928POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA
#929SUPPRESSOR OF AP-1
#930Vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#931METHODS OF EXPRESSING A POLYPEPTIDE IN THE BRAIN AND NUCLEIC ACID CONSTRUCTS CAPABLE OF SAME
#932Expression of factor IX in gene therapy vectors
#933THERAPEUTIC RETROVIRAL VECTORS FOR GENE THERAPY
#934PANCREATIC STELLATE CELL SPECIFIC PROMOTER AND USES THEREOF
#935Methods concerning PPAR delta and antagonists thereof
#936Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#937RECOMBINANT ADENOVIRUS COMPRISING TISSUE-SPECIFIC PROMOTER AND TUMOR-TARGETING TRANS-SPLICING RIBOZYME AND USES THEREOF
#938Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
#939Regulation of endogenous gene expression in cells using zinc finger proteins
#940Transgenic fish and uses thereof
#941ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#942Gene vector for inducing transgene-specific immune tolerance
#943Methods of treating hypertension
#944Muscle-specific expression vectors
#945METHOD OF TREATMENT USING ANTIMICROBIAL COMPOSITION
#946PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESIS
#947In vivo production of small interfering RNAs that mediate gene silencing
#948PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME
#949TRANSGENIC MAMMALS AND CELL LINES FOR THE IDENTIFICATION OF GLUTAMATE TRANSPORTER MODULATORS
#950In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#951In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#952METHODS TO TREAT SOLID TUMORS
#953Liver-specific nucleic acid regulatory elements and methods and use thereof
#954Methods of treating inflammatory intestinal disease and managing symptoms thereof
#955Compositions and Systems for the Regulation of Genes
#956Light-Activated Proton Pumps and Applications Thereof
#957TRANSGENIC ANIMALS EXPRESSING ANTIBODIES SPECIFIC FOR GENES OF INTEREST AND USES THEREOF
#958Method for detecting adeno-associated virus
#959Shortened Alk1 regulatory fragment
#960Targeting TGF-β as a therapy for Alzheimer's disease
#961RAB3B for treatment and prevention of Parkinson's disease
#962Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#963METHOD OF TREATING GENETIC DISORDERS
#964Telomelysin/GFP-expressing recombinant virus
#965Promoter and viral vector containing the same
#966MicroRNA-Formatted Multitarget Interfering RNA Vector Constructs and Methods of Using The Same
#967NUCLEIC ACID MOLECULE AND METHOD OF TARGETING GENE EXPRESSION TO GLIOMAS
#968MUTANT MUSCLE-SPECIFIC ENHANCERS
#969USE OF P27KIP1 FOR THE PREVENTION AND TREATMENT OF HEART FAILURE
#970PROCESS FOR PRODUCING EXOGENOUS PROTEIN IN THE MILK OF TRANSGENIC MAMMALS AND A PROCESS FOR PURIFYING PROTEINS THEREFROM
#971Optimized high yield synthetic plasmids
#972MAO-B ELEVATION AS AN EARLY PARKINSON'S DISEASE BIOMARKER
#973Mesothelioma Specific Transferred Promoter And Use Thereof
#974Method for expression of small RNA molecules within a cell
#975TRANSGENIC RABBITS PRODUCING HUMAN FACTOR VII
#976Composition and method for imaging stem cells
#977TRANSGENIC MAMALS MODIFIELD IN BRI PROTEIN EXPRESSION
#978STEM CELL EXPRESSION CASSETTES
#979Methods and compositions for expressing negative-sense viral RNA in canine cells
#980Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
#981THERAPEUTIC REGIMEN FOR TREATING CANCER
#982Truncated activin type II receptor and methods of use
#983Targeted integration into stem cells
#984METHODS FOR IDENTIFICATION AND SELECTION OF HUMAN EMBRYONIC STEM CELL DERIVED CELLS
#985Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and BPH
#986Use of regulatory sequences for specific, transient expression in neuronal determined cells
#987Use of regulatory sequences for specific, transient expression in neuronal determined cells
#988Floral transition genes in maize and uses thereof
#989REGULATION OF CARDIAC CONTRACTILITY AND HEART FAILURE PROPENSITY
#990TRANSGENIC PROTEINS FROM MULTI-GENE SYSTEMS, METHODS, COMPOSITIONS, USES AND THE LIKE RELATING THERETO
#991ADENOVIRAL SYSTEMS AND THE USES THEREOF
#992Animal Model Based on Targeted Apoptosis for the Study of Genetic Diseases Such as Parkinson's Disease
#993STG Promoter And Its Use As A Marker For Taste And Oocyte Cells
#994Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair
#995Nucleic acids encoding SOX10 promoter and methods to isolate SOX10 expressing cells
#996POLYNUCLEOTIDE SEQUENCE FOR THE INHIBITION OF PHOSPHOLAMBAN SYNTHESIS
#997TARGETED CELL DEATH
#998POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA
#999Replication-defective arenavirus vectors
#1000COMPOSITIONS AND METHODS FOR TREATMENT OF MELANOMAS
#1001Transgenic Zebrafish Models for Neurodegenerative Diseases
#1002Engineered cellular pathways for programmed autoregulation of differentiation
#1003Expression of Anti-Nociceptive Compounds from Endogenously Regulated Promoters
#1004Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells
#1005Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of Angiogenesis
#1006Transgenic production in bovine saliva
#1007Animal models for demyelination disorders
#1008Alteration of tumor growth using zinc finger proteins
#1009Method of treating or retarding the development of blindness
#1010Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#1011Regulation of endogenous gene expression in cells using zinc finger proteins
#1012DNA regulatory element for the expression of transgenes in neurons of a subject and uses thereof
#1013Diphtheria toxin first open reading frame operably linked to an H19 promoter and a diphtheria toxin second open reading frame operably linked to an IGF-II promoter as nucleic acid construct
#1014Method for increasing cardiac mass and performance
#1015In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#1016Dual expression vector system and screening methods
#1017In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#1018Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#1019Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
#1020Vivo production of small interfering RNAs that mediate gene silencing
#1021In vivo production of small interfering RNAS that mediate gene silencing
#1022CHIMERIC ADENOVIRUS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL USING THE SAME
#1023SYSTEMIC INSULIN-LIKE GROWTH FACTOR-1 THERAPY REDUCES DIABETIC PERIPHERAL NEUROPATHY AND IMPROVES RENAL FUNCTION IN DIABETIC NEPHROPATHY
#1024TRANSGENIC FISH WITH TISSUE-SPECIFIC EXPRESSION
#1025MAMMARY GLAND- SPECIFIC HUMAN ERYTHEROPOIETIN EXPRESSION VECTOR, TRANSGENIC ANIMAL AND METHOD FOR PRODUCING HUMAN ERYTHROPOIETIN USING SAME
#1026METHODS AND COMPOSITIONS FOR EXPRESSING NEGATIVE-SENSE VIRAL RNA IN CANINE CELLS
#1027NUCLEIC ACID CONSTRUCT SYSTEMS CAPABLE OF DAIGNOSING OR TREATING A CELL STATE
#1028System and method for electroporating a sample
#1029Tissue specific gene therapy treatment
#1030Compositions and methods for retinal transduction and photoreceptor specific transgene expression
#1031Targeting pseudotyped retroviral vectors
#1032SAFE LENTIVIRAL VECTORS FOR TARGETED DELIVERY OF MULTIPLE THERAPEUTIC MOLECULES
#1033Nonhuman model animal lacking the ability to control lymphocyte migration
#1034Muller Cell Specific Gene Therapy
#1035MEANS AND METHODS FOR ISOLATING AND DETERMINING NOVEL TARGETS FOR THE TREATMENT OF NEURODEGENERATIVE, NEUROLOGICAL OR NEUROPSYCHIATRIC DISORDERS AND COMPOSITIONS COMPRISING THE SAME
#1036METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASE
#1037Oviduct specific expression promoter and recombinant expression vector comprising the same
#1038TARGETED TUMOR THERAPY BY USE OF RECOMBINANT ADENOVIRUS VECTORS THAT SELECTIVELY REPLICATE IN HYPOXIC REGIONS OF TUMORS
#1039Compositions and Methods for Modulating Cognitive Function
#1040Purkinje cell-tropic viral vector
#1041RECOMBINANT CONSTRUCTS AND TRANSGENIC FLUORESCENT ORNAMENTAL FISH THEREFROM
#1042PHOTORECEPTOR PRECURSOR CELLS
#1043Genetically modified animal for use in evaluating harmfulness of test substance
#1044TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf-1 GENE
#1045Adenovirus with mutations in the endoplasmic reticulum retention domain of the E3-19K protein and their use in cancer treatment
#1046Methods for Conditional and Inducible Transgene Espression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells
#1047Polynucleotide
#1048Mitochondrial nucleic acid delivery systems
#1049Double-muscling in mammals
#1050TREATMENT OF PAIN THROUGH EXPRESSION OF OPIOID RECEPTORS
#1051METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION
#1052METHODS AND REAGENTS FOR SCREENING NEW DRUGS AND FOR TREATING ION PUMP ASSOCIATED DISORDERS AND DISEASES
#1053Regulation of angiogenesis with zinc finger proteins
#1054PROTEIN KINASE C IOTA
#1055Production of heterologous protein in the avian oviduct
#1056DEVICES AND METHODS FOR DELIVERING POLYNUCLEOTIDES INTO RETINAL CELLS OF THE MACULA AND FOVEA
#1057Olig1 mini-promoters
#1058Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#1059Animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy
#1060Composition comprising isolated human CTLA4-Fc fusion protein produced in a transgenic chicken
#1061Transgenic non-human animals expressing a truncated activin type II receptor
#1062RECOMBINANT CONSTRUCTS AND TRANSGENIC FLUORESCENT ORNAMENTAL FISH THEREFROM
#1063Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor GM-CSF in tumor cells and uses thereof
#1064Transgenic Frog Lines and Assays Employing Them
#1065Manipulation of Regulatory T Cell and Dc Function By Targeting Neuritin Gene Using Antibodies, Agonists and Antagonists
#1066Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#1067Replication-competent anti-cancer vectors
#1068Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals
#1069Transgenic animal and methods for decreasing cardiac cell death via cardiac-specific sir2alpha overexpression
#1070METHOD FOR THE PRODUCTION OF FUSION PROTEINS IN TRANSGENIC MAMMAL MILK
#1071Prostate Epithelial Androgen Receptor Suppresses Prostate Growth and Tumor Invasion
#1072Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids
#1073CHIMERIC NON-HUMAN ANIMAL
#1074Growth hormone releasing hormone treatment to decrease cholesterol levels
#1075Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
#1076PROMOTER CONSTRUCT
#1077AGENTS FOR TREATING MALIGNANT MESOTHELIOMA
#1078Secreted proteins as markers for cell differentiation
#1079Promoters exhibiting endothelial cell specificity and methods of using same
#1080Genetically Modified Animal and Use Thereof
#1081Methods for producing a protein using an avian lysozyme promoter
#1082Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
#1083S100B mini-promoters
#1084Transgenic Pig with Diabetes and Method for Producing the Same
#1085Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
#1086In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#1087Glutamic acid decarboxylase (GAD) chimera and methods of use
#1088Process of Making Transgenic Mammals That Produce Exogenous Proteins in Milk and Transgenic Mammals Produced Thereby
#1089Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#1090Antibodies produced in a transgenic avian egg white
#1091Cre-lox based gene knockdown constructs and methods of use thereof
#1092Inflammation models in neurodegenerative and arthritic disorders
#1093Small Breast Epithelial Mucin Gene Promoter
#1094Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
#1095Method of treating ocular diseases by gene therapy
#1096Method of ameliorating symptom caused by mood disturbance
#1097Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
#1098Modulation of the integrin-linked kinase signaling pathway provides beneficial human cardiac hypertrophy and post myocardial infarction remodeling
#1099CANCER-SPECIFIC PROMOTERS
#1100Process for Producing Exogenous Protein in the Milk of Transgenic Mammals and a Process For Purifying Proteins Therefrom
#1101Truncated Activin Type II Receptor and Methods of Use
#1102Transgenic Ungulates Expressing CTLA4-IG and Uses Thereof
#1103Methods and protein production using ovomucoid promoters
#1104Transgenic Zebrafish Models for Neurodegenerative Diseases
#1105Use of the ornithine transcarbamylase (), as a marker for diagnosing brain damages
#1106Method of producing sialytransferase-modified proteins
#1107Use of regulatory sequences for specific, transient expression in neuronal determined cells
#1108Expression Vectors Comprising the HS1 Promoter of the VAV1 Oncogene and Use Thereof for the Preparation of Pharmaceutical Compositions Intended for Somatic Gene Therapy
#1109Tissue Specific Expression of Exogenous Proteins in Transgenic Chickens
#1110TRANSGENIC AVIAN WHICH HAS FOREIGN GENE CONTAINING SEQUENCE ENCODING FELINE-DERIVED PROTEIN AND METHOD FOR PRODUCTION THEREOF
#1111Metastatic colon cancer specific promoter and uses thereof
#1112Thymic stromal lymphpoietin promoter and use therefor
#1113Chimeric Non-Human Animal and Use Thereof
#1114ENRICHED PREPARATION OF HUMAN FETAL MULTIPOTENTIAL NEURAL STEM CELLS
#1115Adenoviral vector-based malaria vaccines
#1116THERAPEUTIC METHOD FOR BLOOD COAGULATION DISORDER
#1117Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
#1118ANIMAL MODEL FOR HEPATITIS C VIRUS INFECTION
#1119HBM variants that modulate bone mass and lipid levels
#1120Humanised Baculovirus
#1121Transposition of maize AC/DS elements in vertebrates
#1122Adenovirus vectors containing cell status-specific response elements and methods of use thereof
#1123Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#1124Model animal of schizophrenia
#1125Epididymal lipocalin gene and uses thereof
#1126HSV with a Musashi promoter regulating γ34.5 and ribonucleotide reductase expression
#1127Vector for anti-HPV vaccine and transformed microorganism by the vector
#1128Transgenic animal model for alzheimer's disease
#1129HEH4 Molecules and Uses Thereof
#1130RAAV VECTOR-BASED COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MAMMALIAN DISEASES
#1131Non-invasive, in vivo fluorescent imaging of the nervous system in whole living animal
#1132Glycosylated erythropoietin
#1133Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#1134Composition and method for killing of tumours
#1135Transgenic mouse models of Aβ overexpression
#1136Use of Light Sensitive Genes
#1137RECOMBINANT ADENOVIRAL VECTORS AND METHODS OF USE
#1138p300 transgenic animal
#1139Methods for producing microRNAs
#1140Adenoviral vectors having a protein IX deletion
#1141CYR61 COMPOSITIONS AND METHODS
#1142MAMMALIAN GRAINYHEAD TRANSCRIPTION FACTORS
#1143PREMATURELY AGEING MOUSE MODELS FOR THE ROLE OF DNA DAMAGE IN AGEING AND INTERVENTION IN AGEING-RELATED PATHOLOGY
#1144Method of Treating or Retarding the Development of Blindness
#1145Avian derived erythropoietin
#1146Non-Invasive In Vivo Imaging and Methods for Treating Type I Diabetes
#1147Novel Neural Cell Specific Promoter And Baculovirus And Method For Gene Delivery
#1148Compositions and methods for studying and treating inflammatory diseases and disorders
#1149Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#1150Targeted cell death
#1151Genomic DNA fragments containing regulatory and coding sequences for the B2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments
#1152Cattle beta-casein gene targeting vector using homologous recombination
#1153TRANSGENIC ORGANISM
#1154Humanised Baculovirus
#1155Method of delivery of nucleic acids to peripheral neurons
#1156Amyloid peptide inactivating enzyme to treat alzheimer's disease peripherally
#1157Transgenic non-human animal model of lung tumorigenesis
#1158BISPECIFIC ANTIBODIES
#1159Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
#1160GFAP-BASED GENE THERAPY FOR TREATMENT OF RETINAL DISEASES
#1161Adenoviral vectors having a protein IX deletion
#1162ISOLATION AND GROWTH OF STEM CELLS FROM HEMANGIOMAS
#1163AAV vectors for gene delivery to the lung
#1164Oncolytic Adenovirus Armed with Therapeutic Genes
#1165Fish cancer model
#1166Non-invasive real-time in vivo bioluminescence imaging of local Ca+ dynamics in living organisms
#1167ALK protein tyrosine kinase, cells and methods embodying and using same
#1168System and method for electroporating a sample
#1169COMPOSITIONS AND METHODS FOR REGULATION OF SMOOTH MUSCLE CELLS AND BLOOD PRESSURE
#1170Animal model, cells, and treatment for malignant melanoma
#1171Genetic manipulation method
#1172Preprotachykinin Enhancer Elements
#1173Methods of treating neoplasia with combination target cell-specific adenovirus, chemotherapy and radiation
#1174Transgenic Frog Lines and Assays Employing Them
#1175Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)
#1176Administration of transposon-based vectors to reproductive organs
#1177Gene regulation in transgenic animals using a transposon-based vector
#1178Transgenic animal model
#1179Process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby
#1180Targeting Pseudotyped Retroviral Vectors
#1181Modifier of Organelle Metabolism
#1182Vectors having both isoforms of beta-hexosaminidase and uses of the same
#1183Tumor-Specific Vector for Gene Therapy
#1184Vectors for tissue-specific replication
#1185Method for screening for agents that affect food intake
#1186Cancer-targeted viral vectors
#1187Treating immunodeficiencies by intrathymic injection of nucleotide sequences
#1188In vivo production of small interfering RNAs that mediate gene silencing
#1189COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR CONDITIONS
#1190Expression Vectors and Methods for Obtaining Nk Cell Specific Expression
#1191CODON OPTIMIZED SYNTHETIC PLASMIDS
#1192METHODS FOR TREATING ARTICULAR DISEASE OR DYSFUNCTION USING SELF-COMPLIMENTARY ADENO-ASSOCIATED VIRAL VECTORS
#1193Suppression of Endogenous Immunoglobulin Expression in Non-Human Transgenic Animals
#1194Adenoviral vectors having a protein IX deletion
#1195ADENOVIRAL VECTORS HAVING A PROTEIN IX DELETION
#1196Adenovirus vectors containing cell status-specific response elements and methods of use thereof
#1197Screening assays for hedgehog agonists and antagonists
#1198Transgenic animal
#1199Nonhuman model animal lacking the ability to control lymphocyte migration
#1200Adenovirus vectors containing cell status-specific response elements and methods of use thereof